|
DXCM | Dexcom Inc |
| Surgical & Medical Instruments & Apparatus |
| Book value per $ invested | $ 0.12 |
| Leverage | 63.65% |
| Market Cap | $ 23.0B |
| PE | 32.09 |
| Dividend Yield | 0.00% |
| Profit | $ 717.4m |
| Margin | 15.32% |
DexCom, Inc. is a company that develops, manufactures, and distributes continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with headquarters in San Diego, California, and has a manufacturing facility in Mesa, Arizona.